Literature DB >> 26705676

Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.

Amy R Nelson1, Melanie D Sweeney1, Abhay P Sagare1, Berislav V Zlokovic2.   

Abstract

Vascular insults can initiate a cascade of molecular events leading to neurodegeneration, cognitive impairment, and dementia. Here, we review the cellular and molecular mechanisms in cerebral blood vessels and the pathophysiological events leading to cerebral blood flow dysregulation and disruption of the neurovascular unit and the blood-brain barrier, which all may contribute to the onset and progression of dementia and Alzheimer's disease (AD). Particularly, we examine the link between neurovascular dysfunction and neurodegeneration including the effects of AD genetic risk factors on cerebrovascular functions and clearance of Alzheimer's amyloid-β peptide toxin, and the impact of vascular risk factors, environment, and lifestyle on cerebral blood vessels, which in turn may affect synaptic, neuronal, and cognitive functions. Finally, we examine potential experimental treatments for dementia and AD based on the neurovascular model, and discuss some critical questions to be addressed by future studies. This article is part of a Special Issue entitled: Vascular Contributions to Cognitive Impairment and Dementia edited by M. Paul Murphy, Roderick A. Corriveau and Donna M. Wilcock.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Blood–brain barrier; Dementia; Neurovascular medicine; Neurovascular unit; Vascular factors

Mesh:

Year:  2015        PMID: 26705676      PMCID: PMC4821735          DOI: 10.1016/j.bbadis.2015.12.016

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  242 in total

1.  Hippocampal hypometabolism predicts cognitive decline from normal aging.

Authors:  Lisa Mosconi; Susan De Santi; Juan Li; Wai Hon Tsui; Yi Li; Madhu Boppana; Eugene Laska; Henry Rusinek; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2007-01-11       Impact factor: 4.673

Review 2.  Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer's disease and vascular dementia.

Authors:  Rufus O Akinyemi; Elizabeta B Mukaetova-Ladinska; Johannes Attems; Masafumi Ihara; Raj N Kalaria
Journal:  Curr Alzheimer Res       Date:  2013-07       Impact factor: 3.498

Review 3.  Cerebral microvascular pathology in aging and Alzheimer's disease.

Authors:  E Farkas; P G Luiten
Journal:  Prog Neurobiol       Date:  2001-08       Impact factor: 11.685

4.  Elevated serum matrix metalloproteinase-2 and -9 and their correlations with severity of disease in patients with community-acquired pneumonia.

Authors:  Hacı Ahmet Bircan; Münire Çakir; Ilkay Yilmazer Kapulu; Recep Sütcü; Selçuk Kaya; Onder Öztürk
Journal:  Turk J Med Sci       Date:  2015       Impact factor: 0.973

Review 5.  Sleep and Alzheimer disease pathology--a bidirectional relationship.

Authors:  Yo-El S Ju; Brendan P Lucey; David M Holtzman
Journal:  Nat Rev Neurol       Date:  2013-12-24       Impact factor: 42.937

6.  Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias.

Authors:  Mark Yarchoan; Sharon X Xie; Mitchel A Kling; Jon B Toledo; David A Wolk; Edward B Lee; Vivianna Van Deerlin; Virginia M-Y Lee; John Q Trojanowski; Steven E Arnold
Journal:  Brain       Date:  2012-11-30       Impact factor: 13.501

Review 7.  Recommendations of the Alzheimer's disease-related dementias conference.

Authors:  Thomas J Montine; Walter J Koroshetz; Debra Babcock; Dennis W Dickson; Wendy R Galpern; M Maria Glymour; Steven M Greenberg; Michael L Hutton; David S Knopman; Andrey N Kuzmichev; Jennifer J Manly; Karen S Marder; Bruce L Miller; Creighton H Phelps; William W Seeley; Beth-Anne Sieber; Nina B Silverberg; Margaret Sutherland; Christine L Torborg; Salina P Waddy; Berislav V Zlokovic; Roderick A Corriveau
Journal:  Neurology       Date:  2014-07-30       Impact factor: 9.910

Review 8.  Oral inflammation, tooth loss, risk factors, and association with progression of Alzheimer's disease.

Authors:  Sim K Singhrao; Alice Harding; Tal Simmons; Sarita Robinson; Lakshmyya Kesavalu; StJohn Crean
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

9.  Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast.

Authors:  Sebastian Treusch; Shusei Hamamichi; Jessica L Goodman; Kent E S Matlack; Chee Yeun Chung; Valeriya Baru; Joshua M Shulman; Antonio Parrado; Brooke J Bevis; Julie S Valastyan; Haesun Han; Malin Lindhagen-Persson; Eric M Reiman; Denis A Evans; David A Bennett; Anders Olofsson; Philip L DeJager; Rudolph E Tanzi; Kim A Caldwell; Guy A Caldwell; Susan Lindquist
Journal:  Science       Date:  2011-10-27       Impact factor: 47.728

10.  Effects of a disrupted blood-brain barrier on cholesterol homeostasis in the brain.

Authors:  Ahmed A Saeed; Guillem Genové; Tian Li; Dieter Lütjohann; Maria Olin; Natalia Mast; Irina A Pikuleva; Peter Crick; Yuqin Wang; William Griffiths; Christer Betsholtz; Ingemar Björkhem
Journal:  J Biol Chem       Date:  2014-06-27       Impact factor: 5.157

View more
  147 in total

1.  Increased serum proteins in non-exudative AMD retinas.

Authors:  Hannah Schultz; Ying Song; Bailey H Baumann; Rebecca J Kapphahn; Sandra R Montezuma; Deborah A Ferrington; Joshua L Dunaief
Journal:  Exp Eye Res       Date:  2019-05-31       Impact factor: 3.467

2.  Triglyceride-rich lipoprotein lipolysis products increase blood-brain barrier transfer coefficient and induce astrocyte lipid droplets and cell stress.

Authors:  Linda L Lee; Hnin H Aung; Dennis W Wilson; Steven E Anderson; John C Rutledge; Jennifer M Rutkowsky
Journal:  Am J Physiol Cell Physiol       Date:  2017-01-11       Impact factor: 4.249

Review 3.  Emerging concepts in sporadic cerebral amyloid angiopathy.

Authors:  Andreas Charidimou; Gregoire Boulouis; M Edip Gurol; Cenk Ayata; Brian J Bacskai; Matthew P Frosch; Anand Viswanathan; Steven M Greenberg
Journal:  Brain       Date:  2017-07-01       Impact factor: 13.501

Review 4.  Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.

Authors:  Kassandra Kisler; Amy R Nelson; Axel Montagne; Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

5.  Neurovascular Organotypic Culture Models Using Induced Pluripotent Stem Cells to Assess Adverse Chemical Exposure Outcomes.

Authors:  Eric H Nguyen; Micah J Dombroe; Debra L Fisk; William T Daly; Christine M Sorenson; William L Murphy; Nader Sheibani
Journal:  Appl In Vitro Toxicol       Date:  2019-06-17

6.  Association of homocysteine, folate, and white matter hyperintensities in Parkinson's patients with different motor phenotypes.

Authors:  Yuan Shen; Zhi-Feng Dong; Ping-Lei Pan; Gang Xu; Jun-Ying Huang; Chun-Feng Liu
Journal:  Neurol Sci       Date:  2019-05-04       Impact factor: 3.307

7.  Hippocampal blood-brain barrier permeability is related to the APOE4 mutation status of elderly individuals without dementia.

Authors:  Won-Jin Moon; Changmok Lim; Il Heon Ha; Yeahoon Kim; Yeonsil Moon; Hee-Jin Kim; Seol-Heui Han
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-16       Impact factor: 6.200

8.  Intermittent hypoxia training protects cerebrovascular function in Alzheimer's disease.

Authors:  Eugenia B Manukhina; H Fred Downey; Xiangrong Shi; Robert T Mallet
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10

Review 9.  Locus Coeruleus Modulates Neuroinflammation in Parkinsonism and Dementia.

Authors:  Filippo Sean Giorgi; Francesca Biagioni; Alessandro Galgani; Nicola Pavese; Gloria Lazzeri; Francesco Fornai
Journal:  Int J Mol Sci       Date:  2020-11-16       Impact factor: 5.923

10.  Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer's disease.

Authors:  Anna Csiszar; Stefano Tarantini; Gábor A Fülöp; Tamas Kiss; M Noa Valcarcel-Ares; Veronica Galvan; Zoltan Ungvari; Andriy Yabluchanskiy
Journal:  Geroscience       Date:  2017-08-29       Impact factor: 7.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.